Examination of the oral cavity as an important diagnostic tool of a primary care physician

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Rational use of one of the physical methods of examination - examination of oral cavity - in general medical practice can be effective not only in identifying dental pathology, but also pathology of internal organs. The article describes changes in the lips, oral mucosa and dental system that accompany diseases of the respiratory and cardiovascular systems, gastrointestinal tract and hepatobiliary system, hematopoietic and endocrine systems, kidneys, rheumatic diseases and can be detected by examination. An adequate and, as early as possible, assessment of such manifestations will allow you to correctly build the diagnostic route of the patient, timely identify and treat the underlying disease, as well as save the patient from complex and expensive dental procedures.

Full Text

Restricted Access

About the authors

Albina A. Gazdanova

I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: al.gazdanova@gmail.com
ORCID iD: 0000-0001-7099-4547

PhD in Medical Sciences, associate professor of the Department of clinical pharmacology and propaedeutics of internal diseases, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Russian Federation, 119435, Moscow,11/4 Rossolimo Str.

Anzhela S. Plieva

North Ossetian State Medical Academy of the Ministry of Healthcare of Russia

Email: al.gazdanova@gmail.com
ORCID iD: 0000-0002-9250-7284

PhD in Medical Sciences, assistant at the Department of internal diseases No. 4, North Ossetian State Medical Academy of the Ministry of Healthcare of Russia

Russian Federation, 362001, Vladikavkaz, 39 Barbashova Str.

Svetlana А. Solovieva

I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: s.solovieva@outlook.com
ORCID iD: 0000-0002-2013-3455

PhD in Medical Sciences, assistant at the Department of clinical pharmacology and propaedeutics of internal diseases, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Russian Federation, 119435, Moscow,11/4 Rossolimo Str.

Tatyana M. Ponomarenko

I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: sgdnc@list.ru
ORCID iD: 0000-0002-6733-9493

assistant at the Department of clinical pharmacology and propaedeutics of internal diseases, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Russian Federation, 119435, Moscow,11/4 Rossolimo Str.

References

  1. Knorst J.K., Sfreddo C.S., de F Meira G. et al. Socioeconomic status and oral health-related quality of life: A systematic review and meta-analysis. Community Dent Oral Epidemiol. 2021; 49(2): 95-102. https://dx.doi.org/10.1111/cdoe.12616.
  2. Thomas C., Minty M., Vinel A. et al. Oral microbiota: A major player in the diagnosis of systemic diseases. Diagnostics (Basel). 2021; 11(8): 1376. https://dx.doi.org/10.3390/diagnostics11081376.
  3. Pejcic A. Drug-induced oral reactions. Emerging trends in oral health sciences and dentistry. Ed. by Virdi M. London: InTechOpen. 2015; pp. 567-69. https://dx.doi.org/10.5772/59261. ISBN: 978-953-51-2024-7.
  4. Van Dyke T.E., Kholy K.E., Ishai A. et al. Inflammation of the periodontium associates with risk of future cardiovascular events. J Periodontol. 2021; 92(3): 348-58. https://dx.doi.org/10.1002/JPER.19-0441.
  5. Сергеев Ю.А., Иванюта С.О., Аксенов А.И. Здоровье полости рта и соматическое здоровье: связи между пародонтитом, атеросклерозом и диабетом. Международный журнал прикладных наук и технологий Integral. 2019; 4-1: 7. [Sergeev Y.A., Ivaniuta S.O., Aksenov A.I. Health and somatic health: Links between periodontitis, atherosclerosis and diabetes. International Journal of Applied Sciences and Technologies «Integral». 2019; 4-1: 7 (In Russ.)]. EDN: TCFZRD.
  6. Кукес В.Г., Маринин В.Ф., Реуцкий И.А., Сивков С.И. Врачебные методы диагностики (осмотр, пальпация, перкуссия, аускультация). Учебное пособие для вузов. М.: ГЭОТАР-Медиа. 2006; 720 с. [Kukes V.G., Marinin V.F., Reutsky I.A., Sivkov S.I. Medical diagnostic methods (examination, palpation, percussion, auscultation). Textbook for universities. Moscow: GEOTAR-Media. 2006; 720 pp. (In Russ.)]. ISBN: 5-9704-0262-1.
  7. Наумова В.Н., Туркина С.В., Маслак Е.Е. Взаимосвязь стоматологических и соматических заболеваний: обзор литературы. Волгоградский научно-практический вестник. 2016; (2): 25-27. [Naumova V.N., Turkina S.V., Maslak E.E. Association between oral and general diseases: Review of the literature. Volgogradskiy nauchno-prakticheskiy vestnik = Volgograd Scientific and Practical Bulletin. 2016; (2): 25-27 (In Russ.)]. EDN: WYBZWP.
  8. Трухан Д.И., Багишева Н.В., Лебедев О.И. с соавт. Изменение органа зрения, слизистых оболочек и кожи при заболеваниях органов дыхания. Consilium Medicum. 2019; 21(3):52-55. [Trukhan D.I., Bagisheva N.V., Lebedev O.I. et al. Сhanges in the organ of view, lucious sheets and skin in respiratory diseases. Consilium Medicum. 2019; 21(3):52-55 (In Russ.)]. https://dx.doi.org/10.26442/20751753.2019.3.190209. EDN: PRZKFM.
  9. Wu Z., Xiao C., Chen F. et al. Pulmonary disease and periodontal health: A meta-analysis. Sleep Breath. 2022; 26(4): 1857-68. https://dx.doi.org/10.1007/s11325-022-02577-3.
  10. Kelly N., Winning L., Irwin C. et al. Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: A systematic review. BMC Oral Health. 2021; 21(1): 425. https://dx.doi.org/10.1186/s12903-021-01757-z.
  11. De Rossi S.S., Ciarrocca K.M., Alawi F. Oral ulcerations in a patient with severe asthma. J Am Dent Assoc. 2010; 141(1): 47-51. https://dx.doi.org/10.14219/jada.archive.2010.0020.
  12. Fathima R., Shenoy R., Jodalli P.S. et al. Evaluation of salivary parameters and oral health status among asthmatic and nonasthmatic adult patients visiting a tertiary care hospital. Cureus. 2019; 11(10): e5957. https://dx.doi.org/10.7759/cureus.5957.
  13. Macikowska K., Paruzel-Pliskowska A., Curlej-Wądrzyk A. et al. The condition of the oral cavity in patients receiving chronic steroid therapy - Practical remarks. Pol Merkur Lekarski. 2021; 49(293): 382-84.
  14. Gomez-Casado C., Sanchez-Solares J., Izquierdo E. et al. Oral mucosa as a potential site for diagnosis and treatment of allergic and autoimmune diseases. Foods. 2021; 10(5): 970. https://dx.doi.org/10.3390/foods10050970.
  15. Yu Y.H., Chasman D.I., Buring J.E. et al. Cardiovascular risks associated with incident and prevalent periodontal disease. J Clin Periodontol. 2015; 42(1): 21-28. https://dx.doi.org/10.1111/jcpe.12335.
  16. Larvin H., Kang J., Aggarwal V.R. et al. Risk of incident cardiovascular disease in people with periodontal disease: A systematic review and meta-analysis. Clin Exp Dent Res. 2021; 7(1): 109-22. https://dx.doi.org/10.1002/cre2.336.
  17. Газданова А.А., Пономаренко Т.М., Соловьева С.А. с соавт. Стоматологические проявления соматических заболеваний. Профилактическая медицина. 2022; 25(1): 104-110. [Gazdanova A.A., Ponomarenko T.M., Solovieva S.A. et al. Dental manifestations of somatic diseases. Profilakticheskaya meditsina = Preventive Medicine. 2022; 25(1): 104-110 (In Russ.)]. https://dx.doi.org/10.17116/profmed202225011104. EDN: QLRFEK.
  18. Глебова Л.И., Терехов Г.А., Фирфаров К.В. Пузырно-сосудистый синдром в практике врача стоматолога и терапевта. Стоматолог-практик. 2015; (1): 66-67. [Glebova L.I., Terekhov G.A., Firfarov K.V. Vesicovascular syndrome in the practice of a dentist and therapist. Stomatolog-praktik = Dentist-practitioner. 2015; (1): 66-67 (In Russ.)].
  19. Молочкова Ю.В., Молочков В.А., Изварина Д.С. Синдром Гриншпана-Потекаева. Клиническая дерматология и венерология. 2017; 16(6): 50-53. [Molochkova Iu.V., Molochkov V.A., Izvarina D.S. Grynszpan-Potekaev syndrome. Klinicheskaya dermatologiya i venerologiya = Clinical Dermatology and Venereology. 2017; 16(6): 50-53 (In Russ.)]. https://dx.doi.org/10.17116/klinderma201716650-53. EDN: YMNLBF.
  20. Lechien J.R., Chiesa-Estomba C.M., Calvo Henriquez C. et al. Laryngopharyngeal reflux, gastroesophageal reflux and dental disorders: A systematic review. PLoS One. 2020; 15(8): e0237581. https://dx.doi.org/10.1371/journal.pone.0237581.
  21. Yanushevich O.O., Maev I.V., Krikheli N.I. et al. Prevalence and risk of dental erosion in patients with gastroesophageal reflux disease: A meta-analysis. Dent J (Basel). 2022; 10(7): 126. https://dx.doi.org/10.3390/dj10070126.
  22. Tungare S., Zafar N., Paranjpe A.G. Halitosis. 2022 Aug 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
  23. Косюга С.Ю., Варванина С.Э. Особенности проявления Helicobacter pylori на слизистой оболочке полости рта. Современные проблемы науки и образования. 2015; (1-1): 1376. [Kocyuga S.Y., Varvanina S.E. Features of the manifestation of Helicobacter pilori on the oral mucosa. Sovremennie problem nauki i obrazovaniya. 2015; (1-1): 1376 (In Russ.)]. EDN: VIEXWL
  24. Оскольский Г.И., Непомнящих Л.М., Юркевич А.В. с соавт. Взаимосвязь патологических проявлений в слизистой оболочке полости рта (СОПР) и заболеваний желудочно-кишечного тракта. Дальневосточный медицинский журнал. 2010; (3): 130-133. [Oskolsky G.I., Nepomnyaschikh L.M., Yurkevich A.V. et al. Interaction of pathological manifestations in the oral mucosa and gastrointestinal tract diseases. Dal`nevostochniy meditsinskiy zhurnal = Far Eastern Medical Journal. 2010; (3): 130-133 (In Russ.)]. EDN: NPFYOX.
  25. Кравченко В.А., Юркевич А.В., Ушницкий И.Д. с соавт. Клинико-морфологические исследования реакций слизистой оболочки рта у пациентов с патологией пищеварительной системы. Медицинский алфавит. 2019; 1(5): 58-62. [Kravchenko V.A., Yurkevich A.V., Ushnitski I.D. et al. Clinical and morphological studies of reactions of oral mucosa patients with digestive system disorders. Meditsinskiy alfavit = Medical Alphabet. 2019; 1(5):58-62 (In Russ.)]. https://dx.doi.org/10.33667/2078-5631-2019-1-5(380)-58-62. EDN: NXCCY.
  26. Цепов Л.М., Цепова Е.Л. Поражение слизистой оболочки рта и языка у лиц с патологией желудочно-кишечного тракта. Вестник Смоленской государственной медицинской академии. 2011; 10(1): 76-78. [Tsepov L.M., Tsepova E.L.The defeat of the mucous membrane of the mouth and tongue in persons with pathology of the gastrointestinal tract. Vestnik Smolenskoy gosudarstvennoy medicinskoy akademii = Bulletin of the Smolensk State Medical Academy. 2011; 10(1): 76-78 (In Russ.)]. EDN: OJDOWR.
  27. Гажва С.И., Касумов Н.С. Стоматологический статус пациентов с хроническими диффузными заболеваниями печени. Научное обозрение. Медицинские науки. 2016; (4): 18-21. [Gazhva S.I., Kasumov N.S. The dental status of patients with chronic diffuse liver diseases. Nauchnoe obozrenie. Meditsinskie nauki = Scientific review. Medical sciences. 2016; (4): 18-21 (In Russ)]. EDN: WLXIKZ.
  28. Yumiko N., Takeshi T. Red complex periodontal pathogens are risk factors for liver cirrhosis. Biomed Rep. 2019; 11(5): 199-206. https://dx.doi.org/10.3892/br.2019.1245.
  29. Furuta M., Ekuni D., Yamamoto T. et al. Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand. 2010; 68(1): 27-33. https://dx.doi.org/10.3109/00016350903291913.
  30. Morita T., Yamazaki Y., Fujiharu C. et al. Serum γ - Glutamyltransferase level is associated with periodontal disease independent of drinking habits in japanese adults. Medical Science Monitor. 2014; 20: 2109-16. https://dx.doi.org/10.12659/MSM.891204.
  31. Lu S.Y., Lin L.H., Lu S.N. et al. Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy. J Dent Sci. 2009; 4(4): 191-97. https://dx.doi.org/10.1016/S1991-7902(09)60026-X.
  32. Grossmann Sde.M., Teixeira R., de Aguiar M.C. et al. Oral mucosal conditions in chronic hepatitis C Brazilian patients: a cross-sectional study. J Public Health Dent. 2009; 69(3): 168-75. https://dx.doi.org/10.1111/j.1752-7325.2009.00119.x.
  33. Han P., Sun D., Yang J. Interaction between periodontitis and liver diseases (Review). Biomedical Reports. 2016; 5(3): 267-76. https://dx.doi.org/10.3892/br.2016.718.
  34. Трухан Л.Ю, Трухан Д.И. Стоматологические проблемы гастроэнтерологических больных и их возможные решения. Медицинский совет. 2016; (19): 134-137. [Trukhan L.Yu., Trukhan D.I. Stomatological patients and their possible solutions. Meditinskiy sovet = Medical Council. 2016; (19): 134-137 (In Russ.)]. https://dx.doi.org/10.21518/2079-701X-2019-14-22-31. EDN: XHUWKR.
  35. Lauritano D., Boccalari E., Di Stasio D. et al. Prevalence of oral lesions and correlation with intestinal symptoms of inflammatory bowel disease: A systematic review. Diagnostics (Basel). 2019; 9(3): 77. https://dx.doi.org/10.3390/diagnostics9030077.
  36. Thomas C., Dimmock M., Gilletta de Saint-Joseph C. et al. How oral specialists can help diagnose and manage extra-digestive inflammatory bowel disease complications. Case Rep Gastroenterol. 2021; 15(1): 276-81. https://dx.doi.org/10.1159/000513156.
  37. Rashpa R.S., Mahajan V.K, Kumar P. et al. Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional study. Indian Dermatol Online J. 2018; 9(1): 20-26. https://dx.doi.org/10.4103/idoj.IDOJ_160_17.
  38. Tajalli F., Mirahmadi S.M., Mozafarpoor S. et al. Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: A cross-sectional study of 49 patients. Dermatol Ther. 2021; 34(4): e15015. https://dx.doi.org/10.1111/dth.15015.
  39. Abrao A.L., Santana C.M., Bezerra A.C. et al. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol Engl Ed. 2016; 56(5): 441-50 (In English, Portuguese). https://dx.doi.org/10.1016/j.rbre.2016.02.006.
  40. Napenas J.J., Brennan M.T., Elad S. Oral manifestations of systemic diseases. Dermatol Clin. 2020; 38(4): 495-505. https://dx.doi.org/10.1016/j.det.2020.05.010.
  41. Vivino F.B. Sjogren’s syndrome: Clinical aspects. Clinical Immunology. 2017; 182: 48-54. https://dx.doi.org/10.1016/j.clim.2017.04.005.
  42. Торгашина А.В. Дифференциальная диагностика болезни Шегрена. Терапия. 2022; 8(2): 96-102. [Torgashina A.V. Differential diagnosis of Siogren’s disease. Terapiya. 2022; 8(2): 96-102 (In Russ.)]. https://dx.doi.org/10.18565/therapy.2022.2.96-102. EDN: JKEQYR.
  43. Benz K., Baulig C., Knippschild S. et al. Prevalence of oral and maxillofacial disorders in patients with systemic scleroderma - A systematic review. Int J Environ Res Public Health. 2021; 18(10): 5238. https://dx.doi.org/10.3390/ijerph18105238.
  44. Alhendi F.J., Werth V.P., Sollecito T.P., Stoopler E.T. Systemic sclerosis: Update for oral health care providers. Spec Care Dentist. 2020; 40(5): 418-30. https://dx.doi.org/10.1111/scd.12492.
  45. Elmahi H., Mernissi F.Z. Sarcoidosis with oral involvement. Pan Afr Med J. 2018; 30: 241. https://dx.doi.org/10.11604/pamj.2018.30.241.12010.
  46. Bagchi S., Shah N., Sheikh M.A., Chatterjee R.P. Oral sarcoidosis aiding in diagnosis of underlying systemic disease. BMJ Case Rep. 2019; 12(11): e232093. https://dx.doi.org/10.1136/bcr-2019-232093.
  47. Benli M., Batool F., Stutz C. et al. Orofacial manifestations and dental management of systemic lupus erythematosus: A review. Oral Dis. 2021; 27(2): 151-67. https://dx.doi.org/10.1111/odi.13271.
  48. Thomas D.C., Kohli D., Chen N. et al. Orofacial manifestations of rheumatoid arthritis and systemic lupus erythematosus: A narrative review. Quintessence Int. 2021 ;52(5): 454-66. https://dx.doi.org/10.3290/j.qi.b1043985.
  49. Mays J.W., Sarmadi M., Moutsopoulos N.M. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract. 2012; 12(3 Suppl): 265-82. https://dx.doi.org/10.1016/S1532-3382(12)70051-9.
  50. Legeret C., Furlano R. Oral ulcers in children - A clinical narrative overview. Ital J Pediatr. 2021; 47(1): 144. https://dx.doi.org/10.1186/s13052-021-01097-2.
  51. Ratcliff J.L. Oral pathogens affect gut inflammation and systemic diseases. J Adv Res Dent Oral Health. 2017; 6(1): 555679. https://dx.doi.org/10.19080/adoh.2017.06.555679.
  52. Колчанова Н.Э., Сахарук Н.А., Тихоновская И.В. Оценка стоматологического статуса и наличия очагов одонтогенной инфекции у пациентов с дерматологической патологией (псориаз, экзема, склеродермия). Вестник Витебского государственного медицинского университета. 2012; 11(3): 100-104. [Kolchanova N.Eh., Sakharuk N.A., Tikhonovskaya I.V. Assessment of the dental status of patients with rheumatoid arthritis. Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta = Bulletin of Vitebsk State Medical University. 2012; 11(3): 100-104 (In Russ.)]. EDN: PCYQKR.
  53. Nwadibia U., Larson E., Fanciullo J. Polymyalgia rheumatica and giant cell arteritis: A review article. S D Med. 2016; 69(3): 121-23.
  54. Hellmann D.B. Temporal arteritis: A cough, toothache, and tongue infarction. JAMA. 2002; 287(22): 2996-3000. https://dx.doi.org/10.1001/jama.287.22.2996.
  55. Parakh M.K., Kasi A., Ayyappan V., Subramani P. Knowledge and awareness of oral manifestations of diabetes mellitus and oral health assessment among diabetes mellitus patients-a cross sectional study. Curr. Diabetes Rev. 2020; 16(2): 156-64. https://dx.doi.org/10.2174/1573399815666190502112603.
  56. Han S.J., Son Y.J., Kim B.H. Association between diabetes mellitus and oral health status in patients with cardiovascular diseases: A nationwide population-based study. Int J Environ Res Public Health. 2021; 18(9): 4889. https://dx.doi.org/10.3390/ijerph18094889.
  57. Minty M., Canceil T., Serino M. et al. Oral microbiota-induced periodontitis: A new risk factor of metabolic diseases. Rev Endocr Metab Disord. 2019; 20(4): 449-59. https://dx.doi.org/10.1007/s11154-019-09526-8.
  58. Wilson S.A., Stem L.A., Bruehlman R.D. Hypothyroidism: Diagnosis and treatment. Am Fam Physician. 2021; 103(10): 605-13.
  59. Hirota Y., Matsushita T. Hyperpigmentation as a clue to Addison disease. Cleve Clin J Med. 2022; 89(9): 498-99. https://dx.doi.org/10.3949/ccjm.89a.21082.
  60. Луцкая И.К. Проявления на слизистой оболочке полости рта заболеваний внутренних органов и СПИДа. Международные обзоры: клиническая практика и здоровье. 2013; (6): 32-53. [Lutskaya I.K. Manifestations of diseases of internal organs and AIDS on the oral mucosa. Mezhdunarodnyye obzory: klinicheskaya praktika i zdorov’ye = International Reviews: Clinical Practice and Health. 2013; (6): 32-53 (In Russ.)]. EDN: SAFRSB.
  61. Franchini M., Rossetti G., Tagliaferri A. et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia. 2005; 11(5): 504-9. https://dx.doi.org/10.1111/j.1365-2516.2005.01132.x.
  62. Zappasodi P., Forno C., Corso A., Lazzarino M. Mucocutaneous paraneoplastic syndromes in hematologic malignancies. Int J Dermatol. 2006; 45(1): 14-22. https://dx.doi.org/10.1111/j.1365-4632.2005.02668.x.
  63. Абдулкадыров К.М., Шуваев В.А., Мартынкевич И.С., Шихбабаева Д.И. Современные представления о диагностике и лечении истинной полицитемии. Вестник гематологии. 2015; 11(1): 4-46. [Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S., Shikhbabaeva D.I. Modern concepts of diagnosis and treatment of polycythemia. Vestnik gematologii = Herald of hematology. 2015; 11(1): 4-46 (In Russ.)]. EDN: TYWELT.
  64. Nagy G., Gyulavari O. Postextractios verzes polycythaemia veras betegeken. Fogorv Sz. 1971; 64(12): 450-53. [Postextraction hemorrhage in patients with polycythemia vera. Fogorv Sz. 1971; 64(12): 450-53 (In Hungarian)].
  65. Трухан Д.И., Сулимов А.Ф., Трухан Л.Ю. Изменения органов и тканей полости рта при новой коронавирусной инфекции (COVID-19). Consilium Medicum. 2022; 24(5): 348-56. [Changes in the organs and tissues of the oral cavity in the new coronavirus infection (COVID-19): A review. Consilium Medicum. 2022; 24(5): 348-56 (In Russ.)]. https://dx.doi.org/10.26442/20751753.2022.5.201755. EDN: LQFTQX.
  66. Андреева И.В., Стецюк О.У. Новый пробиотический штамм Streptococcus salivarius K12 в клинической практике. Клиническая микробиология и антимикробная химиотерапия. 2019; 21(2): 92-99. [Andreeva I.V., Stetsiouk O.U. New probiotic strain Streptococcus salivarius K12 in clinical practice. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2): 92-99 (In Russ.)]. https://dx.doi.org/10.36488/cmac.2019.2.92-99. EDN: FTRIMC.
  67. Кисельникова Л.П., Царев В.Н., Тома Э.И., Подпорин М.С. Клинико-микробиологическая характеристика микробиоценоза полости рта детей и возможности его коррекции с применением пробиотиков на основе саливарных стрептококков. Клиническая стоматология. 2021; 24(4): 24-29. [Kiselnikova L.P., Tsarev V.N., Toma E.I., Podporin M.S. Microbiocenosis of the oral cavity of children: Clinical and microbiological characteristics and correction with probiotics based on salivary StreptococcI. Klinicheskaya stomatologiya = Clinical Dentistry. 2021; 24(4): 24-29 (In Russ.)]. https://dx.doi.org/10.37988/1811-153X_2021_4_24. EDN: YDRZWO.
  68. Hale J.D.F., Jain R., Wescombe P.A. et al. Safety assessment of Streptococcus salivarius M18 a probiotic for oral health. Benef Microbes. 2022; 13(1): 47-60. https://dx.doi.org/10.3920/BM2021.0107.
  69. Di Pierro F., Zanvit A., Nobili P. et al. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: Results of a randomized, controlled study. Clin Cosmet Investig Dent. 2015; 7: 107-13. https://dx.doi.org/10.2147/CCIDE.S93066.
  70. Burton J.P., Drummond B.K., Chilcott C.N. et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol. 2013; 62(Pt 6): 875-84. https://dx.doi.org/10.1099/jmm.0.056663-0.
  71. Bardellini E., Amadori F., Gobbi E. et al. Does Streptococcus salivarius strain M18 assumption make black stains disappear in children? Oral Health Prev Dent. 2020; 18(1): 161-64. https://dx.doi.org/10.3290/j.ohpd.a43359.
  72. Gobbi E., De Francesco M.A., Piccinelli G. et al. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes. Eur Arch Paediatr Dent. 2020; 21(6): 673-77. https://dx.doi.org/10.1007/s40368-020-00512-2
  73. Кравец О.Н., Дерябина Л.В. Клиническая оценка эффективности применения пробиотика на основе Streptococcus salivarius M18 при лечении хронического генерализованного пародонтита легкой степени тяжести. Проблемы медицинской микологии. 2021; 23(2): 96. [Kravets O.N., Deryabina L.V. Clinical evaluation of the effectiveness of probiotics based on Streptococcus salivarius M18 in treatment of periodontal diseases. Problems of medical mycology. 2021; 23(2): 96 (In Russ.)]. EDN: ORDYRU.
  74. Benic G.Z., Farella M., Morgan X.C. et al. Oral probiotics reduce halitosis in patients wearing orthodontic braces: A randomized, triple-blind, placebo-controlled trial. J Breath Res. 2019; 13(3): 036010. https://dx.doi.org/10.1088/1752-7163/ab1c81.
  75. Ishijima S.A., Hayama K., Burton J.P. et al. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol. 2012; 78(7): 2190-99. https://dx.doi.org/10.1128/AEM.07055-11.
  76. Караков К.Г., Власова Т.Н., Оганян А.В. с соавт. Критерии выбора метода коррекции дисбактериоза органов полости рта. Проблемы стоматологии. 2020; 16(2): 17-21 [Karakov K.G., Vlasova T.N., Oganyan A.V. et al. Criteria for choosing the method of correction of disbacteriosis of authorities oral cavity. Problemy stomatologii = Issues of Dentistry. 2020; 16(2): 17-21 (In Russ.)]. https://dx.doi.org/10.18481/2077-7566-20-16-2-17-21.
  77. Wescombe P.A., Hale J.D., Heng N.C., Tagg J.R. Developing oral probiotics from Streptococcus salivarius. Future Microbiol. 2012;7(12): 1355-71. https://dx.doi.org/10.2217/fmb.12.113.
  78. Mokhtar M., Rismayuddin N.A.R., Mat Yassim A.S. et al. Streptococcus salivarius K12 inhibits Candida albicans aggregation, biofilm formation and dimorphism. Biofouling. 2021; 37(7): 767-76. https://dx.doi.org/10.1080/08927014.2021.1967334.
  79. He L., Yang H., Chen Z., Ouyang X. The effect of Streptococcus salivarius K12 on halitosis: A double-blind, randomized, placebo-controlled trial. Probiotics Antimicrob Proteins. 2020; 12(4): 1321-29. https://dx.doi.org/10.1007/s12602-020-09646-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig.1.

Download (69KB)
Indexing metadata
3. Fig.2.

Download (20KB)
Indexing metadata
4. Fig.3.

Download (23KB)
Indexing metadata
5. Fig.4.

Download (22KB)
Indexing metadata
6. Fig.5.

Download (18KB)
Indexing metadata

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies